Canada markets close in 5 hours 19 minutes

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
37.98+1.38 (+3.77%)
As of 10:41AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.12B
Enterprise Value 4.29B
Trailing P/E 114.71
Forward P/E 90.91
PEG Ratio (5 yr expected) 25.70
Price/Sales (ttm)6.06
Price/Book (mrq)7.21
Enterprise Value/Revenue 5.10
Enterprise Value/EBITDA 217.34

Trading Information

Stock Price History

Beta (5Y Monthly) 0.82
52-Week Change 3-0.73%
S&P500 52-Week Change 3-2.90%
52 Week High 344.42
52 Week Low 325.04
50-Day Moving Average 337.18
200-Day Moving Average 334.35

Share Statistics

Avg Vol (3 month) 31.09M
Avg Vol (10 day) 31.14M
Shares Outstanding 5141.8M
Implied Shares Outstanding 6N/A
Float 8140.36M
% Held by Insiders 10.79%
% Held by Institutions 189.93%
Shares Short (Apr 28, 2022) 46.54M
Short Ratio (Apr 28, 2022) 45.45
Short % of Float (Apr 28, 2022) 45.46%
Short % of Shares Outstanding (Apr 28, 2022) 44.61%
Shares Short (prior month Mar 30, 2022) 47.17M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021


Profit Margin -3.53%
Operating Margin (ttm)-1.74%

Management Effectiveness

Return on Assets (ttm)-0.35%
Return on Equity (ttm)-3.78%

Income Statement

Revenue (ttm)810.46M
Revenue Per Share (ttm)5.75
Quarterly Revenue Growth (yoy)51.60%
Gross Profit (ttm)164.57M
Net Income Avi to Common (ttm)-28.6M
Diluted EPS (ttm)-0.20
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.15B
Total Cash Per Share (mrq)15.14
Total Debt (mrq)1.25B
Total Debt/Equity (mrq)162.11
Current Ratio (mrq)9.75
Book Value Per Share (mrq)5.47

Cash Flow Statement

Operating Cash Flow (ttm)30.8M
Levered Free Cash Flow (ttm)98.5M